Giovanni Vitale1, Stefano Gitto1, Francesco Raimondi2,3, Alessandro Mattiaccio4, Vilma Mantovani4, Ranka Vukotic1, Antonietta D'Errico5, Marco Seri1, Robert B Russell2,3, Pietro Andreone6,7. 1. Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy. 2. CellNetworks, Bioquant, Heidelberg University, Im Neuenheimer Feld 267, 69120, Heidelberg, Germany. 3. Bioochemie Zentrum Heidelberg (BZH), Heidelberg University, Im Neuenheimer Feld 328, 69120, Heidelberg, Germany. 4. Center for Applied Biomedical Research (CRBA), University Hospital, Bologna, Italy. 5. Addari Institute of Oncology and Transplant Pathology, Policlinico S. Orsola-Malpighi, University of Bologna, Bologna, Italy. 6. Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy. pietro.andreone@unibo.it. 7. Department of Medical and Surgical Sciences and Research Center for the Study of Hepatitis, University of Bologna, Italy, Via Massarenti 9, 40138, Bologna, Italy. pietro.andreone@unibo.it.
Abstract
BACKGROUND: Mutations in ATP-transporters ATPB81, ABCB11, and ABCB4 are responsible for progressive familial intrahepatic cholestasis (PFIC) 1, 2 and 3, and recently the gene for tight junction protein-2 (TJP2) has been linked to PFIC4. AIM: As these four genes have been poorly studied in young people and adults, we investigated them in this context here. METHODS: In patients with cryptogenic cholestasis, we analyzed the presence of mutations by high-throughput sequencing. Bioinformatics analyses were performed for mechanistic and functional predictions of their consequences on biomolecular interaction interfaces. RESULTS: Of 108 patients, 48 whose cause of cholestasis was not established were submitted to molecular analysis. Pathogenic/likely pathogenic mutations were found in ten (21%) probands for 13 mutations: two in ATP8B 1, six in ABCB11, two in ABCB4, three in TJP2. We also identified seven variants of uncertain significance: two in ATP8B1, one in ABCB11, two in ABCB4 and two in TJP2. Finally, we identified 11 benign/likely benign variants. Patients with pathogenic/likely pathogenic mutations had higher levels of liver stiffness (measured by FibroScan®) and bile acids, as well as higher rates of cholestatic histological features, compared to the patients without at least likely pathogenic mutations. The multivariate analysis showed that itching was the only independent factor associated with disease-causing mutations (OR 5.801, 95% CI 1.244-27.060, p = 0.025). CONCLUSIONS: Mutations in the genes responsible for PFIC may be involved in both young and adults with cryptogenic cholestasis in a considerable number of cases, including in heterozygous status. Diagnosis should always be suspected, particularly in the presence of itching.
BACKGROUND: Mutations in ATP-transporters ATPB81, ABCB11, and ABCB4 are responsible for progressive familial intrahepatic cholestasis (PFIC) 1, 2 and 3, and recently the gene for tight junction protein-2 (TJP2) has been linked to PFIC4. AIM: As these four genes have been poorly studied in young people and adults, we investigated them in this context here. METHODS: In patients with cryptogenic cholestasis, we analyzed the presence of mutations by high-throughput sequencing. Bioinformatics analyses were performed for mechanistic and functional predictions of their consequences on biomolecular interaction interfaces. RESULTS: Of 108 patients, 48 whose cause of cholestasis was not established were submitted to molecular analysis. Pathogenic/likely pathogenic mutations were found in ten (21%) probands for 13 mutations: two in ATP8B 1, six in ABCB11, two in ABCB4, three in TJP2. We also identified seven variants of uncertain significance: two in ATP8B1, one in ABCB11, two in ABCB4 and two in TJP2. Finally, we identified 11 benign/likely benign variants. Patients with pathogenic/likely pathogenic mutations had higher levels of liver stiffness (measured by FibroScan®) and bile acids, as well as higher rates of cholestatic histological features, compared to the patients without at least likely pathogenic mutations. The multivariate analysis showed that itching was the only independent factor associated with disease-causing mutations (OR 5.801, 95% CI 1.244-27.060, p = 0.025). CONCLUSIONS: Mutations in the genes responsible for PFIC may be involved in both young and adults with cryptogenic cholestasis in a considerable number of cases, including in heterozygous status. Diagnosis should always be suspected, particularly in the presence of itching.
Authors: R Müllenbach; K J Linton; S Wiltshire; N Weerasekera; J Chambers; E Elias; C F Higgins; D G Johnston; M I McCarthy; C Williamson Journal: J Med Genet Date: 2003-05 Impact factor: 6.318
Authors: Daniel F Gudbjartsson; Hannes Helgason; Sigurjon A Gudjonsson; Florian Zink; Asmundur Oddson; Arnaldur Gylfason; Soren Besenbacher; Gisli Magnusson; Bjarni V Halldorsson; Eirikur Hjartarson; Gunnar Th Sigurdsson; Simon N Stacey; Michael L Frigge; Hilma Holm; Jona Saemundsdottir; Hafdis Th Helgadottir; Hrefna Johannsdottir; Gunnlaugur Sigfusson; Gudmundur Thorgeirsson; Jon Th Sverrisson; Solveig Gretarsdottir; G Bragi Walters; Thorunn Rafnar; Bjarni Thjodleifsson; Einar S Bjornsson; Sigurdur Olafsson; Hildur Thorarinsdottir; Thora Steingrimsdottir; Thora S Gudmundsdottir; Asgeir Theodors; Jon G Jonasson; Asgeir Sigurdsson; Gyda Bjornsdottir; Jon J Jonsson; Olafur Thorarensen; Petur Ludvigsson; Hakon Gudbjartsson; Gudmundur I Eyjolfsson; Olof Sigurdardottir; Isleifur Olafsson; David O Arnar; Olafur Th Magnusson; Augustine Kong; Gisli Masson; Unnur Thorsteinsdottir; Agnar Helgason; Patrick Sulem; Kari Stefansson Journal: Nat Genet Date: 2015-03-25 Impact factor: 38.330
Authors: Melissa Sambrotta; Sandra Strautnieks; Efterpi Papouli; Peter Rushton; Barnaby E Clark; David A Parry; Clare V Logan; Lucy J Newbury; Binita M Kamath; Simon Ling; Tassos Grammatikopoulos; Bart E Wagner; John C Magee; Ronald J Sokol; Giorgina Mieli-Vergani; Joshua D Smith; Colin A Johnson; Patricia McClean; Michael A Simpson; A S Knisely; Laura N Bull; Richard J Thompson Journal: Nat Genet Date: 2014-03-09 Impact factor: 38.330
Authors: Emmanuel Gonzales; Sarah A Taylor; Anne Davit-Spraul; Alice Thébaut; Nadège Thomassin; Catherine Guettier; Peter F Whitington; Emmanuel Jacquemin Journal: Hepatology Date: 2016-10-05 Impact factor: 17.425
Authors: Nancy A M van Ooteghem; Leo W J Klomp; Gerard P van Berge-Henegouwen; Roderick H J Houwen Journal: J Hepatol Date: 2002-03 Impact factor: 25.083
Authors: Damian Szklarczyk; Andrea Franceschini; Stefan Wyder; Kristoffer Forslund; Davide Heller; Jaime Huerta-Cepas; Milan Simonovic; Alexander Roth; Alberto Santos; Kalliopi P Tsafou; Michael Kuhn; Peer Bork; Lars J Jensen; Christian von Mering Journal: Nucleic Acids Res Date: 2014-10-28 Impact factor: 16.971
Authors: P H Dixon; S W C van Mil; J Chambers; S Strautnieks; R J Thompson; F Lammert; R Kubitz; V Keitel; A Glantz; L-A Mattsson; H-U Marschall; M Molokhia; G E Moore; K J Linton; C Williamson Journal: Gut Date: 2008-11-05 Impact factor: 23.059
Authors: Ursula Pieper; Benjamin M Webb; Guang Qiang Dong; Dina Schneidman-Duhovny; Hao Fan; Seung Joong Kim; Natalia Khuri; Yannick G Spill; Patrick Weinkam; Michal Hammel; John A Tainer; Michael Nilges; Andrej Sali Journal: Nucleic Acids Res Date: 2013-11-23 Impact factor: 16.971